![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:PRKCE-GPR126 (FusionGDB2 ID:HG5581TG57211) |
Fusion Gene Summary for PRKCE-GPR126 |
![]() |
Fusion gene information | Fusion gene name: PRKCE-GPR126 | Fusion gene ID: hg5581tg57211 | Hgene | Tgene | Gene symbol | PRKCE | GPR126 | Gene ID | 5581 | 57211 |
Gene name | protein kinase C epsilon | adhesion G protein-coupled receptor G6 | |
Synonyms | PKCE|nPKC-epsilon | APG1|DREG|GPR126|LCCS9|PR126|PS1TP2|VIGR | |
Cytomap | ('PRKCE','PRKCE')('ADGRG6','GPR126') 2p21 | 6q24.2 | |
Type of gene | protein-coding | protein-coding | |
Description | protein kinase C epsilon type | adhesion G-protein coupled receptor G6G-protein coupled receptor 126HBV PreS1-transactivated protein 2developmentally regulated G-protein-coupled receptorvascular-inducible G protein-coupled receptor | |
Modification date | 20200327 | 20200313 | |
UniProtAcc | Q02156 | . | |
Ensembl transtripts involved in fusion gene | ENST00000467135, ENST00000306156, ENST00000394874, | ||
Fusion gene scores | * DoF score | 8 X 8 X 5=320 | 3 X 3 X 3=27 |
# samples | 9 | 3 | |
** MAII score | log2(9/320*10)=-1.83007499855769 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: PRKCE [Title/Abstract] AND GPR126 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | PRKCE(46070202)-GPR126(142758571), # samples:2 PRKCE(46070202)-ADGRG6(142758571), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | PRKCE-GPR126 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. PRKCE-GPR126 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. PRKCE-GPR126 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. PRKCE-GPR126 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | PRKCE | GO:0006468 | protein phosphorylation | 18556656 |
Hgene | PRKCE | GO:0018105 | peptidyl-serine phosphorylation | 15695813 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | SKCM | TCGA-EB-A6L9-06A | PRKCE | chr2 | 46070202 | + | ADGRG6 | chr6 | 142758571 | + |
ChimerDB4 | SKCM | TCGA-EB-A6L9-06A | PRKCE | chr2 | 46070202 | - | GPR126 | chr6 | 142758571 | + |
ChimerDB4 | SKCM | TCGA-EB-A6L9-06A | PRKCE | chr2 | 46070202 | + | GPR126 | chr6 | 142758571 | + |
Top |
Fusion Gene ORF analysis for PRKCE-GPR126 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
3UTR-3CDS | ENST00000467135 | ENST00000230173 | PRKCE | chr2 | 46070202 | + | GPR126 | chr6 | 142758571 | + |
3UTR-3CDS | ENST00000467135 | ENST00000296932 | PRKCE | chr2 | 46070202 | + | GPR126 | chr6 | 142758571 | + |
3UTR-3CDS | ENST00000467135 | ENST00000367608 | PRKCE | chr2 | 46070202 | + | GPR126 | chr6 | 142758571 | + |
3UTR-3CDS | ENST00000467135 | ENST00000367609 | PRKCE | chr2 | 46070202 | + | GPR126 | chr6 | 142758571 | + |
3UTR-intron | ENST00000467135 | ENST00000545477 | PRKCE | chr2 | 46070202 | + | GPR126 | chr6 | 142758571 | + |
5CDS-intron | ENST00000306156 | ENST00000545477 | PRKCE | chr2 | 46070202 | + | GPR126 | chr6 | 142758571 | + |
In-frame | ENST00000306156 | ENST00000230173 | PRKCE | chr2 | 46070202 | + | GPR126 | chr6 | 142758571 | + |
In-frame | ENST00000306156 | ENST00000296932 | PRKCE | chr2 | 46070202 | + | GPR126 | chr6 | 142758571 | + |
In-frame | ENST00000306156 | ENST00000367608 | PRKCE | chr2 | 46070202 | + | GPR126 | chr6 | 142758571 | + |
In-frame | ENST00000306156 | ENST00000367609 | PRKCE | chr2 | 46070202 | + | GPR126 | chr6 | 142758571 | + |
intron-3CDS | ENST00000394874 | ENST00000230173 | PRKCE | chr2 | 46070202 | + | GPR126 | chr6 | 142758571 | + |
intron-3CDS | ENST00000394874 | ENST00000296932 | PRKCE | chr2 | 46070202 | + | GPR126 | chr6 | 142758571 | + |
intron-3CDS | ENST00000394874 | ENST00000367608 | PRKCE | chr2 | 46070202 | + | GPR126 | chr6 | 142758571 | + |
intron-3CDS | ENST00000394874 | ENST00000367609 | PRKCE | chr2 | 46070202 | + | GPR126 | chr6 | 142758571 | + |
intron-intron | ENST00000394874 | ENST00000545477 | PRKCE | chr2 | 46070202 | + | GPR126 | chr6 | 142758571 | + |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000306156 | PRKCE | chr2 | 46070202 | + | ENST00000230173 | GPR126 | chr6 | 142758571 | + | 3970 | 739 | 327 | 1085 | 252 |
ENST00000306156 | PRKCE | chr2 | 46070202 | + | ENST00000367608 | GPR126 | chr6 | 142758571 | + | 3912 | 739 | 327 | 1172 | 281 |
ENST00000306156 | PRKCE | chr2 | 46070202 | + | ENST00000296932 | GPR126 | chr6 | 142758571 | + | 3952 | 739 | 327 | 1085 | 252 |
ENST00000306156 | PRKCE | chr2 | 46070202 | + | ENST00000367609 | GPR126 | chr6 | 142758571 | + | 3906 | 739 | 327 | 1172 | 281 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000306156 | ENST00000230173 | PRKCE | chr2 | 46070202 | + | GPR126 | chr6 | 142758571 | + | 0.001055545 | 0.99894446 |
ENST00000306156 | ENST00000367608 | PRKCE | chr2 | 46070202 | + | GPR126 | chr6 | 142758571 | + | 0.000514454 | 0.9994855 |
ENST00000306156 | ENST00000296932 | PRKCE | chr2 | 46070202 | + | GPR126 | chr6 | 142758571 | + | 0.001007888 | 0.99899215 |
ENST00000306156 | ENST00000367609 | PRKCE | chr2 | 46070202 | + | GPR126 | chr6 | 142758571 | + | 0.000526347 | 0.99947363 |
Top |
Fusion Genomic Features for PRKCE-GPR126 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
PRKCE | chr2 | 46070202 | + | GPR126 | chr6 | 142758570 | + | 0.003813563 | 0.99618644 |
PRKCE | chr2 | 46070202 | + | GPR126 | chr6 | 142758570 | + | 0.003813563 | 0.99618644 |
![]() |
![]() |
![]() |
![]() |
Top |
Fusion Protein Features for PRKCE-GPR126 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:46070202/chr6:142758571) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
PRKCE | . |
FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays essential roles in the regulation of multiple cellular processes linked to cytoskeletal proteins, such as cell adhesion, motility, migration and cell cycle, functions in neuron growth and ion channel regulation, and is involved in immune response, cancer cell invasion and regulation of apoptosis. Mediates cell adhesion to the extracellular matrix via integrin-dependent signaling, by mediating angiotensin-2-induced activation of integrin beta-1 (ITGB1) in cardiac fibroblasts. Phosphorylates MARCKS, which phosphorylates and activates PTK2/FAK, leading to the spread of cardiomyocytes. Involved in the control of the directional transport of ITGB1 in mesenchymal cells by phosphorylating vimentin (VIM), an intermediate filament (IF) protein. In epithelial cells, associates with and phosphorylates keratin-8 (KRT8), which induces targeting of desmoplakin at desmosomes and regulates cell-cell contact. Phosphorylates IQGAP1, which binds to CDC42, mediating epithelial cell-cell detachment prior to migration. In HeLa cells, contributes to hepatocyte growth factor (HGF)-induced cell migration, and in human corneal epithelial cells, plays a critical role in wound healing after activation by HGF. During cytokinesis, forms a complex with YWHAB, which is crucial for daughter cell separation, and facilitates abscission by a mechanism which may implicate the regulation of RHOA. In cardiac myocytes, regulates myofilament function and excitation coupling at the Z-lines, where it is indirectly associated with F-actin via interaction with COPB1. During endothelin-induced cardiomyocyte hypertrophy, mediates activation of PTK2/FAK, which is critical for cardiomyocyte survival and regulation of sarcomere length. Plays a role in the pathogenesis of dilated cardiomyopathy via persistent phosphorylation of troponin I (TNNI3). Involved in nerve growth factor (NFG)-induced neurite outgrowth and neuron morphological change independently of its kinase activity, by inhibition of RHOA pathway, activation of CDC42 and cytoskeletal rearrangement. May be involved in presynaptic facilitation by mediating phorbol ester-induced synaptic potentiation. Phosphorylates gamma-aminobutyric acid receptor subunit gamma-2 (GABRG2), which reduces the response of GABA receptors to ethanol and benzodiazepines and may mediate acute tolerance to the intoxicating effects of ethanol. Upon PMA treatment, phosphorylates the capsaicin- and heat-activated cation channel TRPV1, which is required for bradykinin-induced sensitization of the heat response in nociceptive neurons. Is able to form a complex with PDLIM5 and N-type calcium channel, and may enhance channel activities and potentiates fast synaptic transmission by phosphorylating the pore-forming alpha subunit CACNA1B (CaV2.2). In prostate cancer cells, interacts with and phosphorylates STAT3, which increases DNA-binding and transcriptional activity of STAT3 and seems to be essential for prostate cancer cell invasion. Downstream of TLR4, plays an important role in the lipopolysaccharide (LPS)-induced immune response by phosphorylating and activating TICAM2/TRAM, which in turn activates the transcription factor IRF3 and subsequent cytokines production. In differentiating erythroid progenitors, is regulated by EPO and controls the protection against the TNFSF10/TRAIL-mediated apoptosis, via BCL2. May be involved in the regulation of the insulin-induced phosphorylation and activation of AKT1. Phosphorylates NLRP5/MATER and may thereby modulate AKT pathway activation in cumulus cells (PubMed:19542546). {ECO:0000269|PubMed:11884385, ECO:0000269|PubMed:1374067, ECO:0000269|PubMed:15355962, ECO:0000269|PubMed:16757566, ECO:0000269|PubMed:17603037, ECO:0000269|PubMed:17875639, ECO:0000269|PubMed:17875724, ECO:0000269|PubMed:19542546}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PRKCE | chr2:46070202 | chr6:142758571 | ENST00000306156 | + | 2 | 15 | 1_117 | 137 | 738.0 | Domain | C2 |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000230173 | 21 | 26 | 1153_1205 | 1106 | 1222.0 | Compositional bias | Note=Ser-rich | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000296932 | 20 | 25 | 1153_1205 | 1078 | 1194.0 | Compositional bias | Note=Ser-rich | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367608 | 20 | 24 | 1153_1205 | 1078 | 1223.0 | Compositional bias | Note=Ser-rich | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367609 | 21 | 25 | 1153_1205 | 1106 | 1251.0 | Compositional bias | Note=Ser-rich | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000230173 | 21 | 26 | 1114_1221 | 1106 | 1222.0 | Topological domain | Cytoplasmic | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000296932 | 20 | 25 | 1091_1092 | 1078 | 1194.0 | Topological domain | Extracellular | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000296932 | 20 | 25 | 1114_1221 | 1078 | 1194.0 | Topological domain | Cytoplasmic | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367608 | 20 | 24 | 1091_1092 | 1078 | 1223.0 | Topological domain | Extracellular | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367608 | 20 | 24 | 1114_1221 | 1078 | 1223.0 | Topological domain | Cytoplasmic | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367609 | 21 | 25 | 1114_1221 | 1106 | 1251.0 | Topological domain | Cytoplasmic | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000296932 | 20 | 25 | 1093_1113 | 1078 | 1194.0 | Transmembrane | Helical%3B Name%3D7 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367608 | 20 | 24 | 1093_1113 | 1078 | 1223.0 | Transmembrane | Helical%3B Name%3D7 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PRKCE | chr2:46070202 | chr6:142758571 | ENST00000306156 | + | 2 | 15 | 408_668 | 137 | 738.0 | Domain | Protein kinase |
Hgene | PRKCE | chr2:46070202 | chr6:142758571 | ENST00000306156 | + | 2 | 15 | 669_737 | 137 | 738.0 | Domain | AGC-kinase C-terminal |
Hgene | PRKCE | chr2:46070202 | chr6:142758571 | ENST00000306156 | + | 2 | 15 | 414_422 | 137 | 738.0 | Nucleotide binding | ATP |
Hgene | PRKCE | chr2:46070202 | chr6:142758571 | ENST00000306156 | + | 2 | 15 | 169_220 | 137 | 738.0 | Zinc finger | Phorbol-ester/DAG-type 1 |
Hgene | PRKCE | chr2:46070202 | chr6:142758571 | ENST00000306156 | + | 2 | 15 | 242_292 | 137 | 738.0 | Zinc finger | Phorbol-ester/DAG-type 2 |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000230173 | 21 | 26 | 154_356 | 1106 | 1222.0 | Domain | Pentraxin (PTX) | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000230173 | 21 | 26 | 41_149 | 1106 | 1222.0 | Domain | CUB | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000230173 | 21 | 26 | 800_852 | 1106 | 1222.0 | Domain | GPS | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000296932 | 20 | 25 | 154_356 | 1078 | 1194.0 | Domain | Pentraxin (PTX) | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000296932 | 20 | 25 | 41_149 | 1078 | 1194.0 | Domain | CUB | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000296932 | 20 | 25 | 800_852 | 1078 | 1194.0 | Domain | GPS | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367608 | 20 | 24 | 154_356 | 1078 | 1223.0 | Domain | Pentraxin (PTX) | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367608 | 20 | 24 | 41_149 | 1078 | 1223.0 | Domain | CUB | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367608 | 20 | 24 | 800_852 | 1078 | 1223.0 | Domain | GPS | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367609 | 21 | 25 | 154_356 | 1106 | 1251.0 | Domain | Pentraxin (PTX) | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367609 | 21 | 25 | 41_149 | 1106 | 1251.0 | Domain | CUB | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367609 | 21 | 25 | 800_852 | 1106 | 1251.0 | Domain | GPS | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000230173 | 21 | 26 | 842_850 | 1106 | 1222.0 | Motif | Stachel | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000296932 | 20 | 25 | 842_850 | 1078 | 1194.0 | Motif | Stachel | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367608 | 20 | 24 | 842_850 | 1078 | 1223.0 | Motif | Stachel | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367609 | 21 | 25 | 842_850 | 1106 | 1251.0 | Motif | Stachel | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000230173 | 21 | 26 | 41_852 | 1106 | 1222.0 | Region | Inhibits receptor signaling in absence of type IV collagen | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000296932 | 20 | 25 | 41_852 | 1078 | 1194.0 | Region | Inhibits receptor signaling in absence of type IV collagen | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367608 | 20 | 24 | 41_852 | 1078 | 1223.0 | Region | Inhibits receptor signaling in absence of type IV collagen | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367609 | 21 | 25 | 41_852 | 1106 | 1251.0 | Region | Inhibits receptor signaling in absence of type IV collagen | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000230173 | 21 | 26 | 1046_1069 | 1106 | 1222.0 | Topological domain | Cytoplasmic | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000230173 | 21 | 26 | 1091_1092 | 1106 | 1222.0 | Topological domain | Extracellular | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000230173 | 21 | 26 | 38_862 | 1106 | 1222.0 | Topological domain | Extracellular | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000230173 | 21 | 26 | 884_903 | 1106 | 1222.0 | Topological domain | Cytoplasmic | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000230173 | 21 | 26 | 925_929 | 1106 | 1222.0 | Topological domain | Extracellular | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000230173 | 21 | 26 | 951_970 | 1106 | 1222.0 | Topological domain | Cytoplasmic | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000230173 | 21 | 26 | 992_1024 | 1106 | 1222.0 | Topological domain | Extracellular | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000296932 | 20 | 25 | 1046_1069 | 1078 | 1194.0 | Topological domain | Cytoplasmic | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000296932 | 20 | 25 | 38_862 | 1078 | 1194.0 | Topological domain | Extracellular | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000296932 | 20 | 25 | 884_903 | 1078 | 1194.0 | Topological domain | Cytoplasmic | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000296932 | 20 | 25 | 925_929 | 1078 | 1194.0 | Topological domain | Extracellular | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000296932 | 20 | 25 | 951_970 | 1078 | 1194.0 | Topological domain | Cytoplasmic | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000296932 | 20 | 25 | 992_1024 | 1078 | 1194.0 | Topological domain | Extracellular | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367608 | 20 | 24 | 1046_1069 | 1078 | 1223.0 | Topological domain | Cytoplasmic | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367608 | 20 | 24 | 38_862 | 1078 | 1223.0 | Topological domain | Extracellular | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367608 | 20 | 24 | 884_903 | 1078 | 1223.0 | Topological domain | Cytoplasmic | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367608 | 20 | 24 | 925_929 | 1078 | 1223.0 | Topological domain | Extracellular | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367608 | 20 | 24 | 951_970 | 1078 | 1223.0 | Topological domain | Cytoplasmic | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367608 | 20 | 24 | 992_1024 | 1078 | 1223.0 | Topological domain | Extracellular | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367609 | 21 | 25 | 1046_1069 | 1106 | 1251.0 | Topological domain | Cytoplasmic | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367609 | 21 | 25 | 1091_1092 | 1106 | 1251.0 | Topological domain | Extracellular | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367609 | 21 | 25 | 38_862 | 1106 | 1251.0 | Topological domain | Extracellular | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367609 | 21 | 25 | 884_903 | 1106 | 1251.0 | Topological domain | Cytoplasmic | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367609 | 21 | 25 | 925_929 | 1106 | 1251.0 | Topological domain | Extracellular | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367609 | 21 | 25 | 951_970 | 1106 | 1251.0 | Topological domain | Cytoplasmic | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367609 | 21 | 25 | 992_1024 | 1106 | 1251.0 | Topological domain | Extracellular | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000230173 | 21 | 26 | 1025_1045 | 1106 | 1222.0 | Transmembrane | Helical%3B Name%3D5 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000230173 | 21 | 26 | 1070_1090 | 1106 | 1222.0 | Transmembrane | Helical%3B Name%3D6 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000230173 | 21 | 26 | 1093_1113 | 1106 | 1222.0 | Transmembrane | Helical%3B Name%3D7 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000230173 | 21 | 26 | 863_883 | 1106 | 1222.0 | Transmembrane | Helical%3B Name%3D1 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000230173 | 21 | 26 | 904_924 | 1106 | 1222.0 | Transmembrane | Helical%3B Name%3D2 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000230173 | 21 | 26 | 930_950 | 1106 | 1222.0 | Transmembrane | Helical%3B Name%3D3 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000230173 | 21 | 26 | 971_991 | 1106 | 1222.0 | Transmembrane | Helical%3B Name%3D4 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000296932 | 20 | 25 | 1025_1045 | 1078 | 1194.0 | Transmembrane | Helical%3B Name%3D5 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000296932 | 20 | 25 | 1070_1090 | 1078 | 1194.0 | Transmembrane | Helical%3B Name%3D6 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000296932 | 20 | 25 | 863_883 | 1078 | 1194.0 | Transmembrane | Helical%3B Name%3D1 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000296932 | 20 | 25 | 904_924 | 1078 | 1194.0 | Transmembrane | Helical%3B Name%3D2 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000296932 | 20 | 25 | 930_950 | 1078 | 1194.0 | Transmembrane | Helical%3B Name%3D3 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000296932 | 20 | 25 | 971_991 | 1078 | 1194.0 | Transmembrane | Helical%3B Name%3D4 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367608 | 20 | 24 | 1025_1045 | 1078 | 1223.0 | Transmembrane | Helical%3B Name%3D5 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367608 | 20 | 24 | 1070_1090 | 1078 | 1223.0 | Transmembrane | Helical%3B Name%3D6 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367608 | 20 | 24 | 863_883 | 1078 | 1223.0 | Transmembrane | Helical%3B Name%3D1 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367608 | 20 | 24 | 904_924 | 1078 | 1223.0 | Transmembrane | Helical%3B Name%3D2 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367608 | 20 | 24 | 930_950 | 1078 | 1223.0 | Transmembrane | Helical%3B Name%3D3 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367608 | 20 | 24 | 971_991 | 1078 | 1223.0 | Transmembrane | Helical%3B Name%3D4 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367609 | 21 | 25 | 1025_1045 | 1106 | 1251.0 | Transmembrane | Helical%3B Name%3D5 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367609 | 21 | 25 | 1070_1090 | 1106 | 1251.0 | Transmembrane | Helical%3B Name%3D6 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367609 | 21 | 25 | 1093_1113 | 1106 | 1251.0 | Transmembrane | Helical%3B Name%3D7 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367609 | 21 | 25 | 863_883 | 1106 | 1251.0 | Transmembrane | Helical%3B Name%3D1 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367609 | 21 | 25 | 904_924 | 1106 | 1251.0 | Transmembrane | Helical%3B Name%3D2 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367609 | 21 | 25 | 930_950 | 1106 | 1251.0 | Transmembrane | Helical%3B Name%3D3 | |
Tgene | GPR126 | chr2:46070202 | chr6:142758571 | ENST00000367609 | 21 | 25 | 971_991 | 1106 | 1251.0 | Transmembrane | Helical%3B Name%3D4 |
Top |
Fusion Gene Sequence for PRKCE-GPR126 |
![]() |
>68751_68751_1_PRKCE-GPR126_PRKCE_chr2_46070202_ENST00000306156_GPR126_chr6_142758571_ENST00000230173_length(transcript)=3970nt_BP=739nt CAGCCCCCGCGGCTTGCAGCGGAGCCGACAGCTCGTCTTCTCTTCTGGAGGTGCAGCTGGTGGTCGGGGGGAGAGACTTGCTCCAAACAC GGACATCCCCCAGCTCTCCCCCCTCCCTGTTTTCCGTTAGGAACCCGGCGAGGAAATACATGCACTGGCTGAGAATCGCCCGCGCCAGGG CGCAACGCCACAAGGTGTAGGGAGTGTGCGGGGTGGGGCGAAAGGGGACCCAAGAGTCCCTGTGGCTCGGAGTGCCGGGCCGTCGGTTCT TCATTCCTGCCCTCGGGGCAGACGGAGTGACCCCGGCCCCCACTCCCCGCCCCGACCATGGTAGTGTTCAATGGCCTTCTTAAGATCAAA ATCTGCGAGGCCGTGAGCTTGAAGCCCACAGCCTGGTCGCTGCGCCATGCGGTGGGACCCCGGCCGCAGACTTTCCTTCTCGACCCCTAC ATTGCCCTCAATGTGGACGACTCGCGCATCGGCCAAACGGCCACCAAGCAGAAGACCAACAGCCCGGCCTGGCACGACGAGTTCGTCACC GATGTGTGCAACGGACGCAAGATCGAGCTGGCTGTCTTTCACGATGCCCCCATAGGCTACGACGACTTCGTGGCCAACTGCACCATCCAG TTTGAGGAGCTGCTGCAGAACGGGAGCCGCCACTTCGAGGACTGGATTGATCTGGAGCCAGAAGGAAGAGTGTATGTGATCATCGATCTC TCAGGGTCGTCGGGTGAAGGCTTATTTATATTCATCTTCCACTGTGCTATGAAGGAGAATGTTCAGAAACAGTGGCGGCAGCATCTCTGC TGTGGTAGATTTCGGTTAGCAGATAACTCAGATTGGAGTAAGACAGCTACCAATATCATCAAGAAAAGTTCTGATAATCTAGGAAAATCT TTGTCTTCAAGCTCCATTGGTTCCAACTCAACCTATCTTACATCCAAATCTAAATCCAGCTCTACCACCTATTTCAAAAGGAATAGCCAC ACAGATAATGTCTCCTATGAGCATTCCTTCAACAAAAGTGGATCACTCAGACAGTGCTTCCATGGACAAGTCCTTGTCAAAACTGGCCCA TGCTGATGGAGATCAAACATCAATCATCCCTGTCCATCAGGTCATTGATAAGGTCAAGGGTTATTGCAATGCTCATTCAGACAACTTCTA TAAAAATATTATCATGTCAGACACCTTCAGCCACAGCACAAAGTTTTAATGTCTTTAAGAAAAAGAAATCAATCTGCAGAAATGTGAAGA TTTGCAAGCAGTGTAAACTGCAACTAGTGATGTAAATGTGCTATTACCTAGGTAACTGCATATATATAAGGAATGTATTTTGTTAAGAAG GCTTTTGTGAAATTCAGAATTTTTCTTTTTAATATATTTCTTCCATGGAAGAGTTGTCATCACTAAAACTTCAGTACTGAGAGTAACATG ACTCAGTAGCCACAGAAGCTATGATTTGTAAAATATATAATTGAATCAGAGTAATCATAATGCAGGGGAGACATTCAAATTAGAGACAAG GGAGAAGCAATGCTGAGGAAGACCCTAGATAGAGCTCATTTTACTCCACCTAATCGTTATATCTGGATATACCCATTTTCTGCATCTTCT TTCTCAACAATAAAAAATGTAACTATTTTGAATGCCCACAAATCCCATTCCAGTGTTACTTTCTGTGAATGCAGTACCATATTCTCATTT TCAATGACATTTCAACCACAGGCAGAAAAGACTGTTTACTCCTTGACCCAAAGATTAAAAAGGATTTTTTATTATTTTAAATATTACACC TTCAGAACCATAACATGCTTAAGAAAACTTTCCCAAAATGTTGACCTAGTTAAATGAGGCTATATAAATTTCTAATATTTTACTTATTCT ATTCAAGGCATAGGGCCAAAGCATTAAGTATAATTTAATCCCATACATTCGAGTTAAGTTTAGTGTTGATGTTCCATCATTCTGGACCTC CCAGGAGTTGTTTAAGAATGAATCTCTTACACCTCTACTTTTGCCCCTCTACTGTATATTAAGCCCATAGGCTTGTGGGAGGAAGGAGAA TTTCCATTAGGCAAGCTGTATGCAGTGGAATTTTCCTTTTAGGAGACACACAATTAAGACTCTCTGGTTCTGTCCTTGCTTTGGAGACTT TAAGACATTTCCTAAAGCACAAATAAAAGCCTCGTATTTCCCCATTGAGAGTTTTGTTCCAAGGAATATGAAGTGAGACATATGGGTGAG TCATAATAATCAAAATAATTTATGAAGAGCTGGGTCTGCAATAGCTAGTCTAAAAACTACTTGTGTGTCAGTCCTCTGGTTATAGTATAT AAGAGCCTGAGGAGGTCTGGCAAGATAGATGGTGTATTATTTATGGATCAGGCTGCTGCATACAAACCTTGCATACTATTATGCAGCTTA CCTAACTCTCAGACTATTCTGAGTAATGCTTGCTTGCTAATGAATGTATAGGAGACCACATTGTAATTGTTCTTAGATGATGGAGTCCAT GCAGTTTCTTAGAAATCGGTCTCAGTGCATGCTGTGCTTTTTCACATTTGCTCTGGGTTATCTGGGAAGTATCAGGTTCTGGGAGGCAAC AGCATTAAGTGATAAGAAAAGGAGACATTCTGGCAAAGCCAATCTGCTTAAAGGCAAAGTCCAGAACCTGGAACCTAGAGGCCTTTCTCT CTGCACGAAAAACAGGTAGTTTGCAGTCTGAGATATGGGAGAGCTTTTAGGCTACACAGCAACCCAAGGGACCTCTCACCTTTTGCTGAG CTTCAATCAGGAAGCTATTTGCCTGGCTCCAGCAGATGATGAGATAATGAGGTAGTGGGTTTTTTATTACTGTTCCATTTTGCAACATCC TGCAACACCATCCTGGGAGACAAGAGCATTACCCAGCTTGGCTTTCACGGGGGAGGGTTGTATTCAGTAAAAAAGAATAGTAAATATAAG GTCACTGAGATTCTAAGTAAGATAGTAAATCTAAGGTCACTGAGCCAAATCCTTTTCAATAGGCATATATTAACAGGCTGCTTATTTTGG CGGAGGTTACATATGGATGAAAATGAATCTTAGTCACTGAATATTCATATACATTTCCCCCAAAACCTTAGACATTCATAGTAGATTTTA ATTAGTTAGCTTTCTAACTAGTCAGATTTCTGCCCAAAGTGCTTAGTCAATAGTAATTAAGATATAGCTTCAAAAATGGCTTTGCTTTTG ATTTCTACTCATATTCGTATGGCTCCAGAAAAATATTTTTTTCATATTTGACAATGTCAGCTCCACTTTAGAAATTTTCAATAACCAGAT GAGAAAAAAATTAAGAAATTGCTCAAGGGAAACATTTGTAAATGGATTTGAAAGATTGAGCCAAATTCTGTTGTCAGTTCTAAGCATGCA GTTCTCACCTCCATTTAGTCCCCCATCAGAACAGAGGTCAGGAATTTAGCTGGGGAGCCTAAATTTAGTTCAGCTTACCTTTGAGAATAG CATCAATTCAGACTCTCTTTTCATTATGTTTTCTTTTCTTTTTCCCTCTTTTTAAACTACATTGTGTTAGAGTCATAGTCTAGGATCCTG AGAGATTTTCCATTCTTGTCACCATTCACTTGCATTGTAAAGATTTTCTTTGTCTGTTGTTGGCATAGATTCTTTTGTACATATTTATTT ATTTGTGTTTATATATGTCAATTGGTTTCCTTTCTTAGCTTGATATTGCCTAGCTTTGTTGTTTTAATTAACTTTCTATTAGAGAGACTG TATATATTTTTTCTAAATACTTTGTGAAATCATTTTTGGTAGCAATATCTTTGAATATGATGAATAAAAGTGACTGTGAGTGCAAATAGA ATTAGCAGTAAGAAGCTACTCTAGCTAATTTGCCATTTTACTTAAATGGAAAATGTTTTTCAAATAAATACTTATGTTGTTCATGTTCCA >68751_68751_1_PRKCE-GPR126_PRKCE_chr2_46070202_ENST00000306156_GPR126_chr6_142758571_ENST00000230173_length(amino acids)=252AA_BP=137 MVVFNGLLKIKICEAVSLKPTAWSLRHAVGPRPQTFLLDPYIALNVDDSRIGQTATKQKTNSPAWHDEFVTDVCNGRKIELAVFHDAPIG YDDFVANCTIQFEELLQNGSRHFEDWIDLEPEGRVYVIIDLSGSSGEGLFIFIFHCAMKENVQKQWRQHLCCGRFRLADNSDWSKTATNI -------------------------------------------------------------- >68751_68751_2_PRKCE-GPR126_PRKCE_chr2_46070202_ENST00000306156_GPR126_chr6_142758571_ENST00000296932_length(transcript)=3952nt_BP=739nt CAGCCCCCGCGGCTTGCAGCGGAGCCGACAGCTCGTCTTCTCTTCTGGAGGTGCAGCTGGTGGTCGGGGGGAGAGACTTGCTCCAAACAC GGACATCCCCCAGCTCTCCCCCCTCCCTGTTTTCCGTTAGGAACCCGGCGAGGAAATACATGCACTGGCTGAGAATCGCCCGCGCCAGGG CGCAACGCCACAAGGTGTAGGGAGTGTGCGGGGTGGGGCGAAAGGGGACCCAAGAGTCCCTGTGGCTCGGAGTGCCGGGCCGTCGGTTCT TCATTCCTGCCCTCGGGGCAGACGGAGTGACCCCGGCCCCCACTCCCCGCCCCGACCATGGTAGTGTTCAATGGCCTTCTTAAGATCAAA ATCTGCGAGGCCGTGAGCTTGAAGCCCACAGCCTGGTCGCTGCGCCATGCGGTGGGACCCCGGCCGCAGACTTTCCTTCTCGACCCCTAC ATTGCCCTCAATGTGGACGACTCGCGCATCGGCCAAACGGCCACCAAGCAGAAGACCAACAGCCCGGCCTGGCACGACGAGTTCGTCACC GATGTGTGCAACGGACGCAAGATCGAGCTGGCTGTCTTTCACGATGCCCCCATAGGCTACGACGACTTCGTGGCCAACTGCACCATCCAG TTTGAGGAGCTGCTGCAGAACGGGAGCCGCCACTTCGAGGACTGGATTGATCTGGAGCCAGAAGGAAGAGTGTATGTGATCATCGATCTC TCAGGGTCGTCGGGTGAAGGCTTATTTATATTCATCTTCCACTGTGCTATGAAGGAGAATGTTCAGAAACAGTGGCGGCAGCATCTCTGC TGTGGTAGATTTCGGTTAGCAGATAACTCAGATTGGAGTAAGACAGCTACCAATATCATCAAGAAAAGTTCTGATAATCTAGGAAAATCT TTGTCTTCAAGCTCCATTGGTTCCAACTCAACCTATCTTACATCCAAATCTAAATCCAGCTCTACCACCTATTTCAAAAGGAATAGCCAC ACAGATAATGTCTCCTATGAGCATTCCTTCAACAAAAGTGGATCACTCAGACAGTGCTTCCATGGACAAGTCCTTGTCAAAACTGGCCCA TGCTGATGGAGATCAAACATCAATCATCCCTGTCCATCAGGTCATTGATAAGGTCAAGGGTTATTGCAATGCTCATTCAGACAACTTCTA TAAAAATATTATCATGTCAGACACCTTCAGCCACAGCACAAAGTTTTAATGTCTTTAAGAAAAAGAAATCAATCTGCAGAAATGTGAAGA TTTGCAAGCAGTGTAAACTGCAACTAGTGATGTAAATGTGCTATTACCTAGGTAACTGCATATATATAAGGAATGTATTTTGTTAAGAAG GCTTTTGTGAAATTCAGAATTTTTCTTTTTAATATATTTCTTCCATGGAAGAGTTGTCATCACTAAAACTTCAGTACTGAGAGTAACATG ACTCAGTAGCCACAGAAGCTATGATTTGTAAAATATATAATTGAATCAGAGTAATCATAATGCAGGGGAGACATTCAAATTAGAGACAAG GGAGAAGCAATGCTGAGGAAGACCCTAGATAGAGCTCATTTTACTCCACCTAATCGTTATATCTGGATATACCCATTTTCTGCATCTTCT TTCTCAACAATAAAAAATGTAACTATTTTGAATGCCCACAAATCCCATTCCAGTGTTACTTTCTGTGAATGCAGTACCATATTCTCATTT TCAATGACATTTCAACCACAGGCAGAAAAGACTGTTTACTCCTTGACCCAAAGATTAAAAAGGATTTTTTATTATTTTAAATATTACACC TTCAGAACCATAACATGCTTAAGAAAACTTTCCCAAAATGTTGACCTAGTTAAATGAGGCTATATAAATTTCTAATATTTTACTTATTCT ATTCAAGGCATAGGGCCAAAGCATTAAGTATAATTTAATCCCATACATTCGAGTTAAGTTTAGTGTTGATGTTCCATCATTCTGGACCTC CCAGGAGTTGTTTAAGAATGAATCTCTTACACCTCTACTTTTGCCCCTCTACTGTATATTAAGCCCATAGGCTTGTGGGAGGAAGGAGAA TTTCCATTAGGCAAGCTGTATGCAGTGGAATTTTCCTTTTAGGAGACACACAATTAAGACTCTCTGGTTCTGTCCTTGCTTTGGAGACTT TAAGACATTTCCTAAAGCACAAATAAAAGCCTCGTATTTCCCCATTGAGAGTTTTGTTCCAAGGAATATGAAGTGAGACATATGGGTGAG TCATAATAATCAAAATAATTTATGAAGAGCTGGGTCTGCAATAGCTAGTCTAAAAACTACTTGTGTGTCAGTCCTCTGGTTATAGTATAT AAGAGCCTGAGGAGGTCTGGCAAGATAGATGGTGTATTATTTATGGATCAGGCTGCTGCATACAAACCTTGCATACTATTATGCAGCTTA CCTAACTCTCAGACTATTCTGAGTAATGCTTGCTTGCTAATGAATGTATAGGAGACCACATTGTAATTGTTCTTAGATGATGGAGTCCAT GCAGTTTCTTAGAAATCGGTCTCAGTGCATGCTGTGCTTTTTCACATTTGCTCTGGGTTATCTGGGAAGTATCAGGTTCTGGGAGGCAAC AGCATTAAGTGATAAGAAAAGGAGACATTCTGGCAAAGCCAATCTGCTTAAAGGCAAAGTCCAGAACCTGGAACCTAGAGGCCTTTCTCT CTGCACGAAAAACAGGTAGTTTGCAGTCTGAGATATGGGAGAGCTTTTAGGCTACACAGCAACCCAAGGGACCTCTCACCTTTTGCTGAG CTTCAATCAGGAAGCTATTTGCCTGGCTCCAGCAGATGATGAGATAATGAGGTAGTGGGTTTTTTATTACTGTTCCATTTTGCAACATCC TGCAACACCATCCTGGGAGACAAGAGCATTACCCAGCTTGGCTTTCACGGGGGAGGGTTGTATTCAGTAAAAAAGAATAGTAAATATAAG GTCACTGAGATTCTAAGTAAGATAGTAAATCTAAGGTCACTGAGCCAAATCCTTTTCAATAGGCATATATTAACAGGCTGCTTATTTTGG CGGAGGTTACATATGGATGAAAATGAATCTTAGTCACTGAATATTCATATACATTTCCCCCAAAACCTTAGACATTCATAGTAGATTTTA ATTAGTTAGCTTTCTAACTAGTCAGATTTCTGCCCAAAGTGCTTAGTCAATAGTAATTAAGATATAGCTTCAAAAATGGCTTTGCTTTTG ATTTCTACTCATATTCGTATGGCTCCAGAAAAATATTTTTTTCATATTTGACAATGTCAGCTCCACTTTAGAAATTTTCAATAACCAGAT GAGAAAAAAATTAAGAAATTGCTCAAGGGAAACATTTGTAAATGGATTTGAAAGATTGAGCCAAATTCTGTTGTCAGTTCTAAGCATGCA GTTCTCACCTCCATTTAGTCCCCCATCAGAACAGAGGTCAGGAATTTAGCTGGGGAGCCTAAATTTAGTTCAGCTTACCTTTGAGAATAG CATCAATTCAGACTCTCTTTTCATTATGTTTTCTTTTCTTTTTCCCTCTTTTTAAACTACATTGTGTTAGAGTCATAGTCTAGGATCCTG AGAGATTTTCCATTCTTGTCACCATTCACTTGCATTGTAAAGATTTTCTTTGTCTGTTGTTGGCATAGATTCTTTTGTACATATTTATTT ATTTGTGTTTATATATGTCAATTGGTTTCCTTTCTTAGCTTGATATTGCCTAGCTTTGTTGTTTTAATTAACTTTCTATTAGAGAGACTG TATATATTTTTTCTAAATACTTTGTGAAATCATTTTTGGTAGCAATATCTTTGAATATGATGAATAAAAGTGACTGTGAGTGCAAATAGA >68751_68751_2_PRKCE-GPR126_PRKCE_chr2_46070202_ENST00000306156_GPR126_chr6_142758571_ENST00000296932_length(amino acids)=252AA_BP=137 MVVFNGLLKIKICEAVSLKPTAWSLRHAVGPRPQTFLLDPYIALNVDDSRIGQTATKQKTNSPAWHDEFVTDVCNGRKIELAVFHDAPIG YDDFVANCTIQFEELLQNGSRHFEDWIDLEPEGRVYVIIDLSGSSGEGLFIFIFHCAMKENVQKQWRQHLCCGRFRLADNSDWSKTATNI -------------------------------------------------------------- >68751_68751_3_PRKCE-GPR126_PRKCE_chr2_46070202_ENST00000306156_GPR126_chr6_142758571_ENST00000367608_length(transcript)=3912nt_BP=739nt CAGCCCCCGCGGCTTGCAGCGGAGCCGACAGCTCGTCTTCTCTTCTGGAGGTGCAGCTGGTGGTCGGGGGGAGAGACTTGCTCCAAACAC GGACATCCCCCAGCTCTCCCCCCTCCCTGTTTTCCGTTAGGAACCCGGCGAGGAAATACATGCACTGGCTGAGAATCGCCCGCGCCAGGG CGCAACGCCACAAGGTGTAGGGAGTGTGCGGGGTGGGGCGAAAGGGGACCCAAGAGTCCCTGTGGCTCGGAGTGCCGGGCCGTCGGTTCT TCATTCCTGCCCTCGGGGCAGACGGAGTGACCCCGGCCCCCACTCCCCGCCCCGACCATGGTAGTGTTCAATGGCCTTCTTAAGATCAAA ATCTGCGAGGCCGTGAGCTTGAAGCCCACAGCCTGGTCGCTGCGCCATGCGGTGGGACCCCGGCCGCAGACTTTCCTTCTCGACCCCTAC ATTGCCCTCAATGTGGACGACTCGCGCATCGGCCAAACGGCCACCAAGCAGAAGACCAACAGCCCGGCCTGGCACGACGAGTTCGTCACC GATGTGTGCAACGGACGCAAGATCGAGCTGGCTGTCTTTCACGATGCCCCCATAGGCTACGACGACTTCGTGGCCAACTGCACCATCCAG TTTGAGGAGCTGCTGCAGAACGGGAGCCGCCACTTCGAGGACTGGATTGATCTGGAGCCAGAAGGAAGAGTGTATGTGATCATCGATCTC TCAGGGTCGTCGGGTGAAGGCTTATTTATATTCATCTTCCACTGTGCTATGAAGGAGAATGTTCAGAAACAGTGGCGGCAGCATCTCTGC TGTGGTAGATTTCGGTTAGCAGATAACTCAGATTGGAGTAAGACAGCTACCAATATCATCAAGAAAAGTTCTGATAATCTAGGAAAATCT TTGTCTTCAAGCTCCATTGGTTCCAACTCAACCTATCTTACATCCAAATCTAAATCCAGCTCTACCACCTATTTCAAAAGGAATAGCCAC ACAGACAGTGCTTCCATGGACAAGTCCTTGTCAAAACTGGCCCATGCTGATGGAGATCAAACATCAATCATCCCTGTCCATCAGGTCATT GATAAGGTCAAGGGTTATTGCAATGCTCATTCAGACAACTTCTATAAAAATATTATCATGTCAGACACCTTCAGCCACAGCACAAAGTTT TAATGTCTTTAAGAAAAAGAAATCAATCTGCAGAAATGTGAAGATTTGCAAGCAGTGTAAACTGCAACTAGTGATGTAAATGTGCTATTA CCTAGGTAACTGCATATATATAAGGAATGTATTTTGTTAAGAAGGCTTTTGTGAAATTCAGAATTTTTCTTTTTAATATATTTCTTCCAT GGAAGAGTTGTCATCACTAAAACTTCAGTACTGAGAGTAACATGACTCAGTAGCCACAGAAGCTATGATTTGTAAAATATATAATTGAAT CAGAGTAATCATAATGCAGGGGAGACATTCAAATTAGAGACAAGGGAGAAGCAATGCTGAGGAAGACCCTAGATAGAGCTCATTTTACTC CACCTAATCGTTATATCTGGATATACCCATTTTCTGCATCTTCTTTCTCAACAATAAAAAATGTAACTATTTTGAATGCCCACAAATCCC ATTCCAGTGTTACTTTCTGTGAATGCAGTACCATATTCTCATTTTCAATGACATTTCAACCACAGGCAGAAAAGACTGTTTACTCCTTGA CCCAAAGATTAAAAAGGATTTTTTATTATTTTAAATATTACACCTTCAGAACCATAACATGCTTAAGAAAACTTTCCCAAAATGTTGACC TAGTTAAATGAGGCTATATAAATTTCTAATATTTTACTTATTCTATTCAAGGCATAGGGCCAAAGCATTAAGTATAATTTAATCCCATAC ATTCGAGTTAAGTTTAGTGTTGATGTTCCATCATTCTGGACCTCCCAGGAGTTGTTTAAGAATGAATCTCTTACACCTCTACTTTTGCCC CTCTACTGTATATTAAGCCCATAGGCTTGTGGGAGGAAGGAGAATTTCCATTAGGCAAGCTGTATGCAGTGGAATTTTCCTTTTAGGAGA CACACAATTAAGACTCTCTGGTTCTGTCCTTGCTTTGGAGACTTTAAGACATTTCCTAAAGCACAAATAAAAGCCTCGTATTTCCCCATT GAGAGTTTTGTTCCAAGGAATATGAAGTGAGACATATGGGTGAGTCATAATAATCAAAATAATTTATGAAGAGCTGGGTCTGCAATAGCT AGTCTAAAAACTACTTGTGTGTCAGTCCTCTGGTTATAGTATATAAGAGCCTGAGGAGGTCTGGCAAGATAGATGGTGTATTATTTATGG ATCAGGCTGCTGCATACAAACCTTGCATACTATTATGCAGCTTACCTAACTCTCAGACTATTCTGAGTAATGCTTGCTTGCTAATGAATG TATAGGAGACCACATTGTAATTGTTCTTAGATGATGGAGTCCATGCAGTTTCTTAGAAATCGGTCTCAGTGCATGCTGTGCTTTTTCACA TTTGCTCTGGGTTATCTGGGAAGTATCAGGTTCTGGGAGGCAACAGCATTAAGTGATAAGAAAAGGAGACATTCTGGCAAAGCCAATCTG CTTAAAGGCAAAGTCCAGAACCTGGAACCTAGAGGCCTTTCTCTCTGCACGAAAAACAGGTAGTTTGCAGTCTGAGATATGGGAGAGCTT TTAGGCTACACAGCAACCCAAGGGACCTCTCACCTTTTGCTGAGCTTCAATCAGGAAGCTATTTGCCTGGCTCCAGCAGATGATGAGATA ATGAGGTAGTGGGTTTTTTATTACTGTTCCATTTTGCAACATCCTGCAACACCATCCTGGGAGACAAGAGCATTACCCAGCTTGGCTTTC ACGGGGGAGGGTTGTATTCAGTAAAAAAGAATAGTAAATATAAGGTCACTGAGATTCTAAGTAAGATAGTAAATCTAAGGTCACTGAGCC AAATCCTTTTCAATAGGCATATATTAACAGGCTGCTTATTTTGGCGGAGGTTACATATGGATGAAAATGAATCTTAGTCACTGAATATTC ATATACATTTCCCCCAAAACCTTAGACATTCATAGTAGATTTTAATTAGTTAGCTTTCTAACTAGTCAGATTTCTGCCCAAAGTGCTTAG TCAATAGTAATTAAGATATAGCTTCAAAAATGGCTTTGCTTTTGATTTCTACTCATATTCGTATGGCTCCAGAAAAATATTTTTTTCATA TTTGACAATGTCAGCTCCACTTTAGAAATTTTCAATAACCAGATGAGAAAAAAATTAAGAAATTGCTCAAGGGAAACATTTGTAAATGGA TTTGAAAGATTGAGCCAAATTCTGTTGTCAGTTCTAAGCATGCAGTTCTCACCTCCATTTAGTCCCCCATCAGAACAGAGGTCAGGAATT TAGCTGGGGAGCCTAAATTTAGTTCAGCTTACCTTTGAGAATAGCATCAATTCAGACTCTCTTTTCATTATGTTTTCTTTTCTTTTTCCC TCTTTTTAAACTACATTGTGTTAGAGTCATAGTCTAGGATCCTGAGAGATTTTCCATTCTTGTCACCATTCACTTGCATTGTAAAGATTT TCTTTGTCTGTTGTTGGCATAGATTCTTTTGTACATATTTATTTATTTGTGTTTATATATGTCAATTGGTTTCCTTTCTTAGCTTGATAT TGCCTAGCTTTGTTGTTTTAATTAACTTTCTATTAGAGAGACTGTATATATTTTTTCTAAATACTTTGTGAAATCATTTTTGGTAGCAAT ATCTTTGAATATGATGAATAAAAGTGACTGTGAGTGCAAATAGAATTAGCAGTAAGAAGCTACTCTAGCTAATTTGCCATTTTACTTAAA >68751_68751_3_PRKCE-GPR126_PRKCE_chr2_46070202_ENST00000306156_GPR126_chr6_142758571_ENST00000367608_length(amino acids)=281AA_BP=137 MVVFNGLLKIKICEAVSLKPTAWSLRHAVGPRPQTFLLDPYIALNVDDSRIGQTATKQKTNSPAWHDEFVTDVCNGRKIELAVFHDAPIG YDDFVANCTIQFEELLQNGSRHFEDWIDLEPEGRVYVIIDLSGSSGEGLFIFIFHCAMKENVQKQWRQHLCCGRFRLADNSDWSKTATNI IKKSSDNLGKSLSSSSIGSNSTYLTSKSKSSSTTYFKRNSHTDSASMDKSLSKLAHADGDQTSIIPVHQVIDKVKGYCNAHSDNFYKNII -------------------------------------------------------------- >68751_68751_4_PRKCE-GPR126_PRKCE_chr2_46070202_ENST00000306156_GPR126_chr6_142758571_ENST00000367609_length(transcript)=3906nt_BP=739nt CAGCCCCCGCGGCTTGCAGCGGAGCCGACAGCTCGTCTTCTCTTCTGGAGGTGCAGCTGGTGGTCGGGGGGAGAGACTTGCTCCAAACAC GGACATCCCCCAGCTCTCCCCCCTCCCTGTTTTCCGTTAGGAACCCGGCGAGGAAATACATGCACTGGCTGAGAATCGCCCGCGCCAGGG CGCAACGCCACAAGGTGTAGGGAGTGTGCGGGGTGGGGCGAAAGGGGACCCAAGAGTCCCTGTGGCTCGGAGTGCCGGGCCGTCGGTTCT TCATTCCTGCCCTCGGGGCAGACGGAGTGACCCCGGCCCCCACTCCCCGCCCCGACCATGGTAGTGTTCAATGGCCTTCTTAAGATCAAA ATCTGCGAGGCCGTGAGCTTGAAGCCCACAGCCTGGTCGCTGCGCCATGCGGTGGGACCCCGGCCGCAGACTTTCCTTCTCGACCCCTAC ATTGCCCTCAATGTGGACGACTCGCGCATCGGCCAAACGGCCACCAAGCAGAAGACCAACAGCCCGGCCTGGCACGACGAGTTCGTCACC GATGTGTGCAACGGACGCAAGATCGAGCTGGCTGTCTTTCACGATGCCCCCATAGGCTACGACGACTTCGTGGCCAACTGCACCATCCAG TTTGAGGAGCTGCTGCAGAACGGGAGCCGCCACTTCGAGGACTGGATTGATCTGGAGCCAGAAGGAAGAGTGTATGTGATCATCGATCTC TCAGGGTCGTCGGGTGAAGGCTTATTTATATTCATCTTCCACTGTGCTATGAAGGAGAATGTTCAGAAACAGTGGCGGCAGCATCTCTGC TGTGGTAGATTTCGGTTAGCAGATAACTCAGATTGGAGTAAGACAGCTACCAATATCATCAAGAAAAGTTCTGATAATCTAGGAAAATCT TTGTCTTCAAGCTCCATTGGTTCCAACTCAACCTATCTTACATCCAAATCTAAATCCAGCTCTACCACCTATTTCAAAAGGAATAGCCAC ACAGACAGTGCTTCCATGGACAAGTCCTTGTCAAAACTGGCCCATGCTGATGGAGATCAAACATCAATCATCCCTGTCCATCAGGTCATT GATAAGGTCAAGGGTTATTGCAATGCTCATTCAGACAACTTCTATAAAAATATTATCATGTCAGACACCTTCAGCCACAGCACAAAGTTT TAATGTCTTTAAGAAAAAGAAATCAATCTGCAGAAATGTGAAGATTTGCAAGCAGTGTAAACTGCAACTAGTGATGTAAATGTGCTATTA CCTAGGTAACTGCATATATATAAGGAATGTATTTTGTTAAGAAGGCTTTTGTGAAATTCAGAATTTTTCTTTTTAATATATTTCTTCCAT GGAAGAGTTGTCATCACTAAAACTTCAGTACTGAGAGTAACATGACTCAGTAGCCACAGAAGCTATGATTTGTAAAATATATAATTGAAT CAGAGTAATCATAATGCAGGGGAGACATTCAAATTAGAGACAAGGGAGAAGCAATGCTGAGGAAGACCCTAGATAGAGCTCATTTTACTC CACCTAATCGTTATATCTGGATATACCCATTTTCTGCATCTTCTTTCTCAACAATAAAAAATGTAACTATTTTGAATGCCCACAAATCCC ATTCCAGTGTTACTTTCTGTGAATGCAGTACCATATTCTCATTTTCAATGACATTTCAACCACAGGCAGAAAAGACTGTTTACTCCTTGA CCCAAAGATTAAAAAGGATTTTTTATTATTTTAAATATTACACCTTCAGAACCATAACATGCTTAAGAAAACTTTCCCAAAATGTTGACC TAGTTAAATGAGGCTATATAAATTTCTAATATTTTACTTATTCTATTCAAGGCATAGGGCCAAAGCATTAAGTATAATTTAATCCCATAC ATTCGAGTTAAGTTTAGTGTTGATGTTCCATCATTCTGGACCTCCCAGGAGTTGTTTAAGAATGAATCTCTTACACCTCTACTTTTGCCC CTCTACTGTATATTAAGCCCATAGGCTTGTGGGAGGAAGGAGAATTTCCATTAGGCAAGCTGTATGCAGTGGAATTTTCCTTTTAGGAGA CACACAATTAAGACTCTCTGGTTCTGTCCTTGCTTTGGAGACTTTAAGACATTTCCTAAAGCACAAATAAAAGCCTCGTATTTCCCCATT GAGAGTTTTGTTCCAAGGAATATGAAGTGAGACATATGGGTGAGTCATAATAATCAAAATAATTTATGAAGAGCTGGGTCTGCAATAGCT AGTCTAAAAACTACTTGTGTGTCAGTCCTCTGGTTATAGTATATAAGAGCCTGAGGAGGTCTGGCAAGATAGATGGTGTATTATTTATGG ATCAGGCTGCTGCATACAAACCTTGCATACTATTATGCAGCTTACCTAACTCTCAGACTATTCTGAGTAATGCTTGCTTGCTAATGAATG TATAGGAGACCACATTGTAATTGTTCTTAGATGATGGAGTCCATGCAGTTTCTTAGAAATCGGTCTCAGTGCATGCTGTGCTTTTTCACA TTTGCTCTGGGTTATCTGGGAAGTATCAGGTTCTGGGAGGCAACAGCATTAAGTGATAAGAAAAGGAGACATTCTGGCAAAGCCAATCTG CTTAAAGGCAAAGTCCAGAACCTGGAACCTAGAGGCCTTTCTCTCTGCACGAAAAACAGGTAGTTTGCAGTCTGAGATATGGGAGAGCTT TTAGGCTACACAGCAACCCAAGGGACCTCTCACCTTTTGCTGAGCTTCAATCAGGAAGCTATTTGCCTGGCTCCAGCAGATGATGAGATA ATGAGGTAGTGGGTTTTTTATTACTGTTCCATTTTGCAACATCCTGCAACACCATCCTGGGAGACAAGAGCATTACCCAGCTTGGCTTTC ACGGGGGAGGGTTGTATTCAGTAAAAAAGAATAGTAAATATAAGGTCACTGAGATTCTAAGTAAGATAGTAAATCTAAGGTCACTGAGCC AAATCCTTTTCAATAGGCATATATTAACAGGCTGCTTATTTTGGCGGAGGTTACATATGGATGAAAATGAATCTTAGTCACTGAATATTC ATATACATTTCCCCCAAAACCTTAGACATTCATAGTAGATTTTAATTAGTTAGCTTTCTAACTAGTCAGATTTCTGCCCAAAGTGCTTAG TCAATAGTAATTAAGATATAGCTTCAAAAATGGCTTTGCTTTTGATTTCTACTCATATTCGTATGGCTCCAGAAAAATATTTTTTTCATA TTTGACAATGTCAGCTCCACTTTAGAAATTTTCAATAACCAGATGAGAAAAAAATTAAGAAATTGCTCAAGGGAAACATTTGTAAATGGA TTTGAAAGATTGAGCCAAATTCTGTTGTCAGTTCTAAGCATGCAGTTCTCACCTCCATTTAGTCCCCCATCAGAACAGAGGTCAGGAATT TAGCTGGGGAGCCTAAATTTAGTTCAGCTTACCTTTGAGAATAGCATCAATTCAGACTCTCTTTTCATTATGTTTTCTTTTCTTTTTCCC TCTTTTTAAACTACATTGTGTTAGAGTCATAGTCTAGGATCCTGAGAGATTTTCCATTCTTGTCACCATTCACTTGCATTGTAAAGATTT TCTTTGTCTGTTGTTGGCATAGATTCTTTTGTACATATTTATTTATTTGTGTTTATATATGTCAATTGGTTTCCTTTCTTAGCTTGATAT TGCCTAGCTTTGTTGTTTTAATTAACTTTCTATTAGAGAGACTGTATATATTTTTTCTAAATACTTTGTGAAATCATTTTTGGTAGCAAT ATCTTTGAATATGATGAATAAAAGTGACTGTGAGTGCAAATAGAATTAGCAGTAAGAAGCTACTCTAGCTAATTTGCCATTTTACTTAAA >68751_68751_4_PRKCE-GPR126_PRKCE_chr2_46070202_ENST00000306156_GPR126_chr6_142758571_ENST00000367609_length(amino acids)=281AA_BP=137 MVVFNGLLKIKICEAVSLKPTAWSLRHAVGPRPQTFLLDPYIALNVDDSRIGQTATKQKTNSPAWHDEFVTDVCNGRKIELAVFHDAPIG YDDFVANCTIQFEELLQNGSRHFEDWIDLEPEGRVYVIIDLSGSSGEGLFIFIFHCAMKENVQKQWRQHLCCGRFRLADNSDWSKTATNI IKKSSDNLGKSLSSSSIGSNSTYLTSKSKSSSTTYFKRNSHTDSASMDKSLSKLAHADGDQTSIIPVHQVIDKVKGYCNAHSDNFYKNII -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for PRKCE-GPR126 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for PRKCE-GPR126 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | PRKCE | Q02156 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | PRKCE | Q02156 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Top |
Related Diseases for PRKCE-GPR126 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | PRKCE | C0020429 | Hyperalgesia | 3 | CTD_human |
Hgene | PRKCE | C0458247 | Allodynia | 3 | CTD_human |
Hgene | PRKCE | C0751211 | Hyperalgesia, Primary | 3 | CTD_human |
Hgene | PRKCE | C0751212 | Hyperalgesia, Secondary | 3 | CTD_human |
Hgene | PRKCE | C0751213 | Tactile Allodynia | 3 | CTD_human |
Hgene | PRKCE | C0751214 | Hyperalgesia, Thermal | 3 | CTD_human |
Hgene | PRKCE | C2936719 | Mechanical Allodynia | 3 | CTD_human |
Hgene | PRKCE | C0002152 | Alloxan Diabetes | 1 | CTD_human |
Hgene | PRKCE | C0009402 | Colorectal Carcinoma | 1 | CTD_human;UNIPROT |
Hgene | PRKCE | C0009404 | Colorectal Neoplasms | 1 | CTD_human |
Hgene | PRKCE | C0011853 | Diabetes Mellitus, Experimental | 1 | CTD_human |
Hgene | PRKCE | C0011881 | Diabetic Nephropathy | 1 | CTD_human |
Hgene | PRKCE | C0013146 | Drug abuse | 1 | CTD_human |
Hgene | PRKCE | C0013170 | Drug habituation | 1 | CTD_human |
Hgene | PRKCE | C0013222 | Drug Use Disorders | 1 | CTD_human |
Hgene | PRKCE | C0017667 | Nodular glomerulosclerosis | 1 | CTD_human |
Hgene | PRKCE | C0023903 | Liver neoplasms | 1 | CTD_human |
Hgene | PRKCE | C0027051 | Myocardial Infarction | 1 | CTD_human |
Hgene | PRKCE | C0029231 | Organic Mental Disorders, Substance-Induced | 1 | CTD_human |
Hgene | PRKCE | C0033141 | Cardiomyopathies, Primary | 1 | CTD_human |
Hgene | PRKCE | C0036529 | Myocardial Diseases, Secondary | 1 | CTD_human |
Hgene | PRKCE | C0038433 | Streptozotocin Diabetes | 1 | CTD_human |
Hgene | PRKCE | C0038580 | Substance Dependence | 1 | CTD_human |
Hgene | PRKCE | C0038586 | Substance Use Disorders | 1 | CTD_human |
Hgene | PRKCE | C0151744 | Myocardial Ischemia | 1 | CTD_human |
Hgene | PRKCE | C0236969 | Substance-Related Disorders | 1 | CTD_human |
Hgene | PRKCE | C0242231 | Coronary Stenosis | 1 | CTD_human |
Hgene | PRKCE | C0345904 | Malignant neoplasm of liver | 1 | CTD_human |
Hgene | PRKCE | C0400966 | Non-alcoholic Fatty Liver Disease | 1 | CTD_human |
Hgene | PRKCE | C0740858 | Substance abuse problem | 1 | CTD_human |
Hgene | PRKCE | C0878544 | Cardiomyopathies | 1 | CTD_human |
Hgene | PRKCE | C1510472 | Drug Dependence | 1 | CTD_human |
Hgene | PRKCE | C3241937 | Nonalcoholic Steatohepatitis | 1 | CTD_human |
Hgene | PRKCE | C4316881 | Prescription Drug Abuse | 1 | CTD_human |
Hgene | PRKCE | C4721453 | Peripheral Nervous System Diseases | 1 | CTD_human |
Tgene | C2700406 | SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 1 (finding) | 1 | CTD_human | |
Tgene | C4225303 | LETHAL CONGENITAL CONTRACTURE SYNDROME 9 | 1 | CTD_human;GENOMICS_ENGLAND;UNIPROT |